Teva Asks High Court To Ax Fed. Circ. Claim Construction Rule

Teva Pharmaceuticals USA Inc. urged the U.S. Supreme Court on Friday to reverse a Federal Circuit decision invalidating one of its patent for its multiple sclerosis drug Copaxone, claiming the appeals court has long overstepped its authority when it comes more

  • Tags: